Back to Trades
Total Value
$6.7M
Filing Date
Nov 20, 2026
1 transaction
Trade Summary
On Nov 19, 2026, Farrell Michael J., Chairman and CEO, Director, reported $6.7M of RESMED INC (RMD) across 1 transaction. The filing covers ResMed Common Stock and reflects balanced net activity of $0. Reported prices ranged from $236.88. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- RESMED INC
- Ticker Symbol
- RMD
- CIK
- 0000943819
Insider Information
- Role
- Chairman and CEO, Director
- Location
- SAN DIEGO, CA
Filing Details
- Filing Date
- Nov 20, 2026
- Transaction Date
- Nov 19, 2026
- Accession Number
- 0000943819-26-000133
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Nov 19, 2026 | ResMed Common Stock | 48,136 | — | Grant/Award | — |
| Nov 19, 2026 | ResMed Common Stock | 28,180.245 | $236.88 | Tax Withholding | $6.7M |
Want live alerts when Farrell Michael J. trades again?
Download Insider Trades to track RMD, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on November 19, 2026, when the compensation and leadership development committee certified that the performance metrics were met for this portion of the grant.
- (F2)Disposition to issuer for tax withholding on vesting of performance-based restricted stock units granted on 11/16/2023.